Craigavon, N.I., UK, - 09 November 2015 - Almac Group, the global contract development and manufacturing organisation, has confirmed a £16 million investment to expand its formulation and analytical ...

Almac has created a new non-GMP formulation development facility and two new analytical laboratories at their U.K. headquarters in Craigavon to expand its drug product pharmaceutical development ...

Firm will initially construct new non-GMP formulation development suite and then add new QC laboratories. Contract research and development firm Almac is to invest £4.5 million into the first phase of ...

To win at the drug development game, it’s not enough to show up with a great molecule. Many compounds would stall at the discovery stage without effective ways to get them inside patients. But the ...

When AstraZeneca ($AZN) abandoned its campus in Charnwood in the U.K. some years back, it left new owners to figure out what would be done with the facilities. Now ...

Almac Group has completed a multi-million-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK. The significant investment by Almac Pharma Services, will ...

Following the success of one of its key client partnered products, Craigavon-based pharmaceutical company Almac, has announced the commercial manufacturing expansion. Together with the recent ...

Almac and VTU Technology have announced their collaboration to offer joint services for the expression of recombinant proteins with site-specific modification and labelling, such as PEGylation for ...

The Almac Group has today announced an £11m investment and the creation of over 100 new jobs to expand its global analytical services capabilities. Over the past 18 months, Almac Sciences and Almac ...

PARSIPPANY, N.J., -- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed a collaboration agreement ...

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Almac Discovery, a ...